This is the authors' abstract. We don't add key points for this paper.
COVID-19 şüpheli hastalarda SARS-CoV-2 ve yaygın solunum yolu patojenleri ile koenfeksiyon Turk Hij Den Biyol Derg, 2024; 81(1): 23 -30 COVID-19 şüpheli hastalarda SARS-CoV-2 ve yaygın solunum yolu patojenleri ile koenfeksiyonCoinfection with SARS-CoV-2 and common respiratory pathogens in patients with suspected COVID-19 Sedef Zeliha ÖNER 1 (ID), Hatice ÖZDEMİR 1 (ID), Melek DEMİR 1 (ID), Ergun METE 1 (ID), İlknur KALELİ 1 (ID), Ahmet ÇALIŞKAN 1 (ID), Çağrı ERGİN 1 (ID) ÖZET Amaç: SARS-CoV-2 ile enfekte hastaların çoğunun klinik semptomları yaygın solunum yolu viral enfeksiyonunda görülen semptomlara benzemektedir.Çalışmamızda, COVID-19 şüphesi olan hastalarda SARS-CoV-2 ve yaygın solunum yolu virüslerinin değerlendirilmesi amaçlanmıştır.Yöntem: Mart 2020 -Mart 2022 tarihleri arasında multipleks solunum PCR paneli ve SARS-CoV-2 RT-PCR testi çalışılan 592 hastanın sonuçları retrospektif olarak değerlendirildi.Yaygın solunum yolu viral patojenler multiplex real-time PCR paneli ile (FTD® Respiratory Pathogens 21 Kit, Fast-Track Diagnostics, Lüksemburg) saptandı.SARS-CoV-2 Real-Time PCR testi, farklı dönemlerde olmak üzere Bio-Seepdy SARS-CoV-2 Double Gene RT-qPCR Kiti, Bio-Speedy® SARS-CoV-2 Emerging Plus, Diagnovital® HS SARS-CoV-2 real time PCR kiti, DS CORONEX COVID-19 Multiplex Real Time-qPCR Test Kitleri kullanılarak incelenmiştir.Bulgular: Örneklerin %63,2'sinde (374/592) viral antijen pozitifliği bulunmuştur.Tek etken pozitifliği %46,3 (274/592), ikili etken %13,9 (82/592), üçlü etken %2,9 (17/592), dörtlü etken pozitifliği %0,2 (1/592) saptanmıştır.SARS-CoV-2 pozitif olan hastaların ABSTRACT Objective: The clinical symptoms of most patients infected with SARS-CoV-2 are similar to the symptoms of common respiratory viral infection.Our study aims to investigate SARS-CoV-2 and common respiratory viruses in patients with suspected COVID-19.Methods: The test results of 592 patients for multiplex respiratory PCR panel and SARS-CoV-2 RT-PCR between March 2020 and March 2022 were studied and retrospectively evaluated.Common respiratory viral pathogens were detected with the multiplex realtime PCR panel (FTD® Respiratory Pathogens 21 Kit, Fast-Track Diagnostics, Luxembourg).The SARS-CoV-2 Real-Time PCR test was evaluated using the Bio-Speedy SARS-CoV-2 Double Gene RT-qPCR Kit, Bio-Speedy® SARS-CoV-2 Emerging Plus, Diagnovital® HS SARS-CoV-2 Real-Time PCR kit, DS CORONEX COVID-19 Multiplex Real-Time Test Kits.Results: Viral antigen positivity was detected in 63.2% (374/592) of the samples.The single-agent positivity was 46.3% (274/592), the dual-agent positivity was 13.9% (82/592), the triple-agent positivity was 2.9% (17/592), and the quadruple-agent positivity was 0.2% (1/592).In 51.5% of SARS-CoV-2 positive patients (17/33), SARS-CoV-2Makale Dili "Türkçe"/Article Language "Turkish"
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Öner et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: